SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG
0
Add to list
GB COVID-19 Ag POCT
Cat. No. 4ECO101E
More details>
(3 items)
SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG About GBC Our Brands R&D Media Join us Contact us
English 繁體中文
Responding to COVID-19: GBC's Mission

Research and Production

In the global fight against the pandemic, where the outbreak was rapidly spreading, timely and precise screening for positive cases was crucial for epidemic control. To address this, GBC collaborated with Kaohsiung Medical University to develop rapid screening test kits for COVID-19. Leveraging automated instruments, we achieved high-throughput screening capability, processing up to 1,440 samples per day. Faced with novel variants of the virus, GBC's products, including RT-PCR nucleic acid test kits, specialized rapid antigen test kits, ELISA antibody test kits, as well as VTM virus collection kits and nucleic acid extraction reagents, have demonstrated outstanding testing performance, with an accuracy rate exceeding 90% for variants such as Alpha, Beta, Gamma, Delta, and Omicron.

Fulfilling Corporate Social Responsibility

During the critical period of the severe COVID-19 situation in Taiwan, when the overall testing capacity was limited, GBC took the initiative to contribute to society and fulfill its corporate responsibility. We donated twenty thousand doses of GB SARS-CoV-2 Real-Time RT-PCR nucleic acid testing reagents to Hsinchu County and City, thereby augmenting the epidemic screening supply capacity and rallying together to combat the pandemic. Additionally, GBC engaged in discussions with the Taipei City governments, health authorities, and hospitals, preparing for immediate emergency support. Our aim is to contribute and assist in the establishment of community screening stations across various locations, ultimately enhancing Taiwan's epidemic monitoring network and safeguarding the health of people throughout the nation.

Foreign Aid

In the global battle against the raging pandemic, GBC has stood firm as the vanguard, playing a crucial role as the frontline in rapid screening and showcasing a sense of international solidarity. Teaming up with Fubon Charity Foundation, we jointly donated 850 sets of ELISA COVID-19 antibody test kits. This generous donation is capable of facilitating testing for up to 81,600 individuals. The Ministry of Foreign Affairs will oversee the distribution of these kits to the Kingdom of Eswatini, a valued diplomatic partner.

Mr. Frank Lin, General Manager of GBC, emphasized that as the world grapples with the relentless onslaught of the pandemic, nations are actively conducting widespread testing and administering vaccines to curb the escalation of the outbreak. This collaborative donation of test kits with Fubon Charity Foundation is a testament to supporting increased interaction between Taiwan and its friendly allied nations. It underscores the concerted efforts of private enterprises, non-profit organizations (NPOs), and governmental bodies in providing international assistance in pandemic supplies. Together, we are uniting to fortify the global defense against the pandemic.
RELATED